Skip to main content
. Author manuscript; available in PMC: 2018 May 1.
Published in final edited form as: Clin Imaging. 2017 Feb 10;43:97–105. doi: 10.1016/j.clinimag.2017.01.015

Table 2.

Costs, Effectiveness and Incremental Cost Effectiveness Ratio for Individuals With a 50% Prevalence of Obstructive CAD

Strategy Cost Effect Δ Cost Δ Effect ICER
ETT-SE-ICA $21,386 15.0391
ETT-MPS-ICA $21,397 15.035 $10 −0.0041 Dominated
ETT-CCTA-ICA $22,070 15.0499 $684 0.0108 $63,294
SE-CCTA-ICA $22,100 15.048 $30 −0.0019 Dominated
MPS-CCTA-ICA $22,116 15.0414 $46 −0.0085 Dominated
SE-ICA $22,195 15.0481 $125 −0.0018 Dominated
MPS-ICA $22,211 15.0414 $141 −0.0085 Dominated
ETT-ICA $22,929 15.0502 $858 0.0003 Ext Dominated
CCTA-SE-ICA $23,124 15.0642 $1,054 0.0143 $73,734
CCTA-MPS-ICA $23,126 15.0637 $2 −0.0005 Dominated
CCTA-ICA $23,295 15.0654 $170 0.0012 $141,900
ICA $24,675 15.0659 $1,380 0.0005 $2,760,880